Views: 89 Author: Site Editor Publish Time: 2023-04-18 Origin: Site
Synthgene provide one-stop solution for mRNA to help mRNA vaccines/drugs development!
As a leading supplier of mRNA raw material, Synthgene have developed GMP nucleotides, modified nucleotides, cap analogs and other core raw materials of GMP grade mRNA vaccines/drugs to meet the commercialization needs! Synthgene mRNA raw materials strictly implement GMP quality management system, has obtained ISO9001 quality management system certification, to meet the requirements of mRNA vaccines/drugs enterprise research and development, production and IND application!
What Synthgene can do
Raw material products
As a leading supplier of mRNA raw materials, we have developed GMP nucleotides, modified nucleotides, cap analogs, etc, as well as we can also customize and synthesize new modified nucleotides and cap analogs with independent intellectual property rights.
mRNA raw materials
PCR raw materials
Oligonucleotide materials
Delivery system raw materials
Bioenzyme raw materials
Veterinary mRNA vaccine
mRNA therapy has the advantages of short development cycle, low cost and high safety. However, as an emerging field, mRNA vaccines/drugs production technology still faces many challenges in the CMC process, especially the optimization of mRNA response system, capping strategy, raw material quality, supply chain management, quality characterization and other problems.
To ensure mRNA vaccines/drugs meet GMP requirements, it is necessary to conduct process development and manufacturing process scale-up studies, thus we can ensure consistency, safety, and efficacy of evolving mRNA product candidates.
We are ready to serve you for your mRNA vaccines/drugs enterprise research and development, production, and IND application needs!
Moving Animal Health and Human Health forward!
Optimize your business today! Contact us right away!